Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2005 1
2007 1
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of psoriasis with oral liarozole: a dose-ranging study.
Berth-Jones J, Todd G, Hutchinson PE, Thestrup-Pedersen K, Vanhoutte FP. Berth-Jones J, et al. Among authors: vanhoutte fp. Br J Dermatol. 2000 Dec;143(6):1170-6. doi: 10.1046/j.1365-2133.2000.03884.x. Br J Dermatol. 2000. PMID: 11122017 Clinical Trial.
Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.
Namour F, Vanhoutte FP, Beetens J, Blockhuys S, De Weer M, Wigerinck P. Namour F, et al. Among authors: vanhoutte fp. Drugs R D. 2012 Sep 1;12(3):141-63. doi: 10.2165/11633120-000000000-00000. Drugs R D. 2012. PMID: 22950522 Free PMC article. Clinical Trial.